<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220723055529N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-04-12</date_registration>
      <primary_sponsor>Kharazmi University</primary_sponsor>
      <public_title>The comparison between effect of adding external and internal focus to plyometric training on agility, lower extremity landing mechanic, performance, balance, strength in subjects with neuromuscular leg dominance deficit.</public_title>
      <acronym></acronym>
      <scientific_title>The comparison between effect of adding external and internal focus to plyometric training on agility, lower extremity landing mechanic, performance, balance, strength in subjects with neuromuscular leg dominance deficit.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>54</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69508</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Other design features: , Randomization description: In this study, researcher initially select 54 sample sizes and then, randomly divided them into 3 groups include: control group (n=18), first experimental group (n=18) ,and second experimental group (n=18). for randomization assignment coding boxes with random order will bee used that their size and forms are similar. thus. thay consist of numbers from 1 to 54 . this proses is so that number 1 to 18 will bee assigned to first experimental group, number 19 to 36 will bee assigned to second experimental group  ,and number 37 to 54 will bee assigned to control group, Blinding description: In this research, participants will be divided into two experimental groups and a control group. At first, They will be informed about research process generally But, They will not informed about research details such as; objectives. In exert phases, the first and second intervention group will be separated then others. Data analysis will be implemented by statical data analysis specialist so that he/she will be received statistical data.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Leg Dominance Neuromuscular Deficit.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: the first intervention group: in this group, participants will execute plyometric training with external focus for 8 weeks (30 minutes). Training phases will be started easy training levels (such as ;bilateral squat jump in place, forward) and will be advanced step by step (such as; unilateral squat jump, unilateral countermovement jump and execution by rope and medicine ball). participants will be exerted squat jump and trainer will be asked them that knees and feet are parallel to embedded cones during landing and knees are bend to cones as high as. Intervention 2: Intervention group: The Second intervention group: in this group, participants will execute plyometric training with internal focus for 8 weeks (30 minutes). Training phases will be started easy training levels (such as ;bilateral squat jump in place, forward) and will be advanced step by step (such as; unilateral squat jump, unilateral countermovement jump and execution by rope and medicine ball). An example for internal focus with squat jump; An example for internal focus with plyometric; participants will be exerted squat jump and trainer will be asked them that knees and feet are parallel, knees aren’t valgus position in landing. Intervention 3: Control group: No One of intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
only part of data as a mean is shard as a paper

When:
September 2023

To whom:
the informatin is confidentional and available for all as a papar

Conditions:
the informatin is confidentional and available for all as a papar

Where to obtain:
Jafar Hamdi Dourbash
j.hamdi65@yahoo.com

How to obtain:
2 months later of publish, data will be sent by email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Jafar Hamdi Dourbash</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bahri Alley, Enghelab Ave.</address>
        <city>Takab</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5991313516</zip>
        <telephone>+98 44 4552 8047</telephone>
        <email>j.hamdi65@yahoo.com</email>
        <affiliation>Kharazmi University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Jafar Hamdi Dourbash</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bahri Alley, Enghelab Ave.</address>
        <city>Takab</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5991313516</zip>
        <telephone>+98 44 4552 8047</telephone>
        <email>j.hamdi65@yahoo.com</email>
        <affiliation>Kharazmi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male and female in 12 to 18 years old.
participants with normal BMI</inclusion_criteria>
      <agemin>12 years</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Individuals with cardiovascular disease history.
individuals with knee surgery history.
participate in similar training about this research.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: the first intervention group: in this group, participants will execute plyometric training with external focus for 8 weeks (30 minutes). Training phases will be started easy training levels (such as ;bilateral squat jump in place, forward) and will be advanced step by step (such as; unilateral squat jump, unilateral countermovement jump and execution by rope and medicine ball). participants will be exerted squat jump and trainer will be asked them that knees and feet are parallel to embedded cones during landing and knees are bend to cones as high as.</i_keyword>
      <i_keyword>Intervention group: The Second intervention group: in this group, participants will execute plyometric training with internal focus for 8 weeks (30 minutes). Training phases will be started easy training levels (such as ;bilateral squat jump in place, forward) and will be advanced step by step (such as; unilateral squat jump, unilateral countermovement jump and execution by rope and medicine ball). An example for internal focus with squat jump; An example for internal focus with plyometric; participants will be exerted squat jump and trainer will be asked them that knees and feet are parallel, knees aren’t valgus position in landing.</i_keyword>
      <i_keyword>Control group: No One of intervention</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Agility. Timepoint: pre and post test. Method of measurement: T agility test.</prim_outcome>
      <prim_outcome>Lower Extremity landing mechanic. Timepoint: pre and post test. Method of measurement: Kinovea Software.</prim_outcome>
      <prim_outcome>Strength. Timepoint: pre and post test. Method of measurement: Dynamometer.</prim_outcome>
      <prim_outcome>Balance. Timepoint: pre and post test. Method of measurement: Y Balance test.</prim_outcome>
      <prim_outcome>Performance. Timepoint: pre and post test. Method of measurement: Single Leg hop and countermovement jump.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kharazmi University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-06-17</approval_date>
        <contact_name>Research Ethics Committees of Sport Sciences Research Institute (SSRI)</contact_name>
        <contact_address>Motahari St, Mirdamad St, Fifth Alley. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
